News | August 19, 2007

Cardiatis Recruits for 3D Multilayer Braided Stent Trial

August 20, 2007 - Cardiatis, SA announced that it has completed recruitment of patients into its first European clinical trial of its 3D Multilayer Braided Stent for repairing aneurysms.

Patient recruitment, which began in December 2006, culminates four years of extensive concept testing that demonstrated the ability of the 3D multilayer stent to repair aneurysms endovascularly without need for coils or stent grafts.

Extensive pre-clinical tests including theoretical simulation utilizing Computerized Fluid Dynamics (CFD), Lattice Boltzmann, and Molecular Modelization methods, in-vitro modeling using Particle Image Velocimetry (PIV) methods as well as a complete in-vivo testing program of different animal aneurysm models have all demonstrated the soundness and feasibility of the fluid dynamic modulation concept for endovascular aneurysm repair.

For more information: www.cardiatis.com


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now